Alice Renard

Alice Renard

Investment Partner

Alice is an Investment Partner of Syncona Investment Management Ltd.

She is also currently Head of Operations at Purespring Therapeutics and works closely with Anaveon. Alice serves as an Observer on the Board of Purespring and Anaveon.

Prior to joining Syncona, Alice was an Investment Banking Analyst within Barclays’ Healthcare Corporate Finance and M&A team, where she worked on transactions involving pharmaceutical and other healthcare companies. Prior to Barclays, Alice worked briefly at AbbVie and Janssen. Alice holds a Doctorate degree in Pharmacy from the University of Lille 2 (School of Pharmacy, Lille, France). She holds a Masters in International Health Policy & Health Economics from the London School of Economics.

Syncona portfolio companies

  • Anaveon (Board observer)
  • Purespring Therapeutics
Martin Murphy

Martin Murphy

Chief Executive Officer
Chris Hollowood

Chris Hollowood

Chief Investment Officer
Edward Hodgkin

Edward Hodgkin

Senior Partner
Elisa Petris

Elisa Petris

Lead Partner
Magdalena Jonikas

Magdalena Jonikas

Lead Partner
Alex Hamilton

Alex Hamilton

Investment Partner
Michael Kyriakides

Michael Kyriakides

Investment Partner
Gonzalo Garcia

Gonzalo Garcia

Investment Partner
Raghd Rostom

Raghd Rostom

Associate Partner
Nathaniel Dahan

Nathaniel Dahan

Associate Partner